Growth Hormone / side effects and safety / Last reviewed 2026-04-04

GHRP-6 Side Effects: Safety Signals and Warnings

GHRP-6 safety concerns are compound-specific. The main listed side effects are Intense hunger, Cortisol elevation, and Prolactin elevation. The main warning signals are Not approved for clinical use in any jurisdiction, Strong appetite stimulation may lead to unwanted weight gain, and Elevates cortisol and prolactin more than newer GHRPs.

Read the full GHRP-6 guide Browse answer pages

Direct Answer

Evidence for GHRP-6 is too preliminary to support a research protocol with confidence for most applications. The compound raises cortisol and prolactin significantly alongside GH, which complicates interpretation and limits practical utility. Of the Growth Hormone secretagogues in this library, ipamorelin or MK-677 are better-evidenced starting points with cleaner side-effect profiles.

Evidence grade
Level C
Research status
Preclinical
Category
Growth Hormone
Best for
Older GHRP receptor pharmacology research, appetite stimulation mechanistic studies

Reported Side Effects

Warnings

Known or Plausible Interactions

Regulatory Context

Not FDA approved. Available as a research chemical. Banned by WADA.

Evidence Snapshot

Evidence gradeLevel C
Research statusPreclinical
Best supported outcomesAppetite Stimulation (Level B), Growth Hormone Release (Level C), and Gastric Motility (Level C)
Primary citation count2
Last reviewed2026-04-04

Related Guides

How to Cite This Page

ExaminePeptides. "GHRP-6 Side Effects: Safety Signals and Warnings." Last reviewed 2026-04-04. https://examinepeptides.com/answers/ghrp-6-side-effects-safety/

This static answer page is built for fast indexing and direct citation. It summarizes the matching full evidence review and links back to primary sources where the source database includes them.